Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.1K Sell
500
-500
-50% -$25.9K ﹤0.01% 2444
2026
Q1
$15.2K Buy
+1,000
New +$46.7K ﹤0.01% 2332

Other funds holding MRNA

SignatureFD's MRNA Position: Q2 2026 in Review

SignatureFD reduced its Moderna (MRNA) stake by 5.5% in Q2 2026, selling an estimated $12K and leaving 4,024 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #932.

SignatureFD first reported a position in MRNA in Q4 2018 and has held it in 29 quarters since. The position peaked at $1.47M in Q3 2021. 171 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • SignatureFD held 4,024 shares of Moderna worth $282K as of Q2 2026.
  • SignatureFD sold 232 Moderna shares in Q2 2026, an estimated $12K.
  • Moderna made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #932 holding.
  • SignatureFD first reported a position in Moderna in Q4 2018 and has held it in 29 quarters since.
  • SignatureFD's Moderna position peaked at $1.47M in Q3 2021.
  • 171 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.